-
Dr. Kathryn J. Fowler: When to Consider Biopsy – Radiologist’s Perspective
-
Dr. Hanchong Toh: Promising Prospects for Immune Adjuvant Therapy in Liver Cancer
-
Dr. Oi-Lin Ng: Heterogeneity of Liver Cancer and its Biological Markers
-
Dr. Linda Wong: Adjuvant Therapy Could Usher in a New Paradigm for Early-Stage Liver Cancer Treatment
-
Dr. Jun Ma: On the immunotherapeutic progress and future trends for acute lymphoblastic leukemia based on the studies at EHA 2023
-
Dr. HuiqiangHuang: Just around the corner! Extranodal NK/T-cell lymphoma is ushering in the era of immunotherapy.
-
Dr. QianJiang: Reduced Dosage without Reducing Efficacy, Better Quality of Life for Patients
-
Dr. Jie Jin: the New JAK Inhibitor Jaktinib in the Treatment of Myelofibrosis (MF)
-
Dr. Huaqing Wang: Primary Mediastinal B-Cell Lymphoma (PMBCL) Benefits More Significantly from Axi-Cel Treatment
-
Interview with Chao Zhuo at ECCMID 2023
-
Dr. Graham Taylor: Understanding and Combatting HTLV-1丨ECCMID 2023
-
Antimicrobial Susceptibility Testing: The Joint Efforts of CLSI and EUCAST丨ECCMID 2023
Connecting Medical Expertise through Media